Selected Publications

Cook, M.R. Williams, L. Kolm, P. Dunleavy, K.: Improved Survival Outcomes for Intensive versus Standard Chemoimmunotherapy in Primary Mediastinal B-cell Lymphoma: A Meta-Analysis of 4068 Patients. Haematologica 109 (3): 2024.

Cook, M.R, Shouval, R. Perales, M, et al.: Real-World Evidence in the United States (US) of the Impact of Bridging Therapy Prior to Axicabtagene Ciloleucel (Axi-Cel) for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL). ASH Annual Conference 2023 : 2023.

Cook, M.R. Dorris, SC. Makambi, K. Luo, Y. Munshi, P. Donato, M. Rowley, S. Saad, A. Goy, A. Dunleavy, K. Ali, A.: Toxicity and Efficacy of Chimeric Antigen Receptor (CAR) T-cell Therapy in Primary and Secondary CNS Lymphoma: A Meta-Analysis of 128 Patients. Blood Adv 7 (1): 32-39,2023.

Shah NJ, Cook MR, Wu T, Lev-Ari SL, Blackburn MB, Serzan MT, Alaoui A, Atkins, MB.: Association Between Immune Checkpoint Inhibitors, Corticosteroids, Immunosuppressive Agents and Opportunistic Infections. Journal of the National Comprehensive Cancer Network 20 (7): 2022.

Shah NJ, Cook MR, Wu T, Lev-Ari SL, Blackburn MB, Serzan MT, Alaoui A, Atkins, MB.: The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids J Natl Compr Canc Netw 20 (7): 800-807.e1.,2022.

Cook, M.R. Dunleavy, K.: Targeting the Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic strategies. Current Oncology Reports 24 : 1121-1131,2022.

Zhang D, Shah NJ, Cook MR, Blackburn M, Serzan MT, Advani S, Potosky AL, Atkins MB, Braithwaite D.: Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers (Basel) 13 (23): 6109,2021.

Cook, M., Dykes, K., White, K., Desale, S., Agrawal, R., Fernandez, S., Huang, X., Cobb, N., Lai, C.: Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19. Clinical Lymphoma, Myeloma & Leukemia : 2021.

Cook, M.R. Karp, J.E. Lai, C.: The Spectrum of Genetic Mutations in Myelodysplastic Syndrome: Should We Update Prognostication? EJHaem 3 (1): 301-313,2021.

Cook, M, Dunleavy K.: Optimizing Outcomes in Primary Mediastinal B-cell Lymphoma – Is R-CHOP enough? Blood Adv 5 (19): 3873-3875. ,2021.

Academic Contact Information

Penn Presbyterian Medical Center
51 N 39th St, 1st Floor PAC building
Philadelphia, PA 19104
Phone: 267-588-2569
Patient appointments: 800-789-7366